Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Total Debt: 2021-2022

Historic Total Debt for Autolus Therapeutics (AUTL) over the last 2 years, with Dec 2022 value amounting to $116,000.

  • Autolus Therapeutics' Total Debt rose 180.95% to $295,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $295,000, marking a year-over-year increase of 180.95%. This contributed to the annual value of $116,000 for FY2022, which is 9.38% down from last year.
  • Per Autolus Therapeutics' latest filing, its Total Debt stood at $116,000 for FY2022, which was down 9.38% from $128,000 recorded in FY2021.
  • In the past 5 years, Autolus Therapeutics' Total Debt ranged from a high of $128,000 in FY2021 and a low of $116,000 during FY2022.
  • Its 2-year average for Total Debt is $122,000, with a median of $122,000 in 2021.
  • Data for Autolus Therapeutics' Total Debt shows a maximum YoY decreased of 9.38% (in 2022) over the last 5 years.
  • Over the past 2 years, Autolus Therapeutics' Total Debt (Yearly) stood at $128,000 in 2021, then decreased by 9.38% to $116,000 in 2022.